FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA issued a supplemental approval for atorvastatin calcium from Biocon Pharma Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)